CORset Versus OstéoSynthese in Adult Pyogenic Spondylodiscitis
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · May 11, 2018
Trial Information
Current as of July 04, 2025
Unknown status
Keywords
ClinConnect Summary
Safety and efficacy of percutaneous for the indication of pyogenic spondylitis has been demonstrated retrospectively on small cohort studies, which is in line with our clinical experience. Although this therapeutic concept seems applicable to patients with spondylitis, the theoretical clinical benefit of minimally invasive surgery remains hypothetic and unclear compared to brace treatment, which might still be regarded as the gold standard.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • adult patients presenting acute pyogenic spondylitis of the thoracolumbar spine
- • back pain at a minimum of 4 out of 10 on VAS
- • Diagnostic MRI and disc puncture + microbiological analysis required for antibiotic treatment and/or blood culture
- • Vertebral body involvement (osteolysis) \< 50% of VB height documented on CT
- Exclusion criteria:
- • postoperative pyogenic spondylitis or infection after spinal instrumentation spinal tuberculosis and mycosis
- • contra-indications for surgery or general anaesthesia
- • general septic conditions acute endocarditis documented by sonography
- • patients presenting another major abcess or an epidural abscess
- • Absence of vertebral body involvement (osteolysis) on CT or minor VB involvement less than 10% of VB height (surgery not indicated)
- • Major destruction of vertebral body (\>50%) on CT (surgery mandatory) Patients with concomitant bacterial endocarditis
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Caen, , France
Grenoble, , France
Bordeaux, , France
Clichy, , France
Dijon, , France
Lyon, , France
Marseille, , France
Montpellier, , France
Nancy, , France
Nantes, , France
Nice, , France
Paris, , France
Paris, , France
Reims, , France
Strasbourg, , France
Patients applied
Trial Officials
Yann Philippe CHARLES, MD
Principal Investigator
Hôpitaux Universitaires de Strasbourg - Service de chirurgie du rachis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials